Thymagen (20mg) is a synthetic dipeptide supplied as a lyophilized powder exclusively for controlled laboratory research. It is not intended for human or animal consumption or for diagnostic, therapeutic, veterinary, food, cosmetic, or dietary-supplement use.
Technical Product Information
| Specification | Details |
|---|---|
| Compound | Thymagen |
| Alternate Name | Thymogen |
| Sequence | Glu-Trp (EW) |
| Molecular Formula | C₁₆H₁₉N₃O₅ |
| Molecular Weight | 333.34 g/mol |
| CAS Number | 38101-59-6 |
| PubChem CID | 100094 |
| Quantity | 20mg per vial |
| Form | Lyophilized peptide powder |
| Purity and Identity | Refer to the lot-specific Certificate of Analysis |
| Intended Application | Controlled in-vitro, analytical, and laboratory research |
| Restrictions | Not for human or animal use, consumption, administration, diagnosis, or therapy |
The chemical identifiers and sequence listed above correspond to the PubChem entry for Thymogen, also identified as glutamyltryptophan or oglufanide.
NordSci Peptides provides access to lot-specific analytical documentation for researchers who require verification of compound identity and analytical quality. Testing results may vary by lot and should be confirmed through the applicable Certificate of Analysis.
The primary concern for peptide researchers today is product purity. Nord-sci guarantees our product purity by performing independent testing of our products and providing those certifications for our customers in our product descriptions.
THIS PRODUCT IS NOT INTENDED TO TREAT, CURE OR DIAGNOSE ANY CONDITION OR DISEASE AND IS NOT FOR HUMAN CONSUMPTION. ALL PRODUCTS OFFERED ARE INTENDED FOR LABORATORY RESEARCH USE ONLY.
All products are produced using lyophilization (freeze-drying), a preservation method that allows peptides to remain fully stable during shipping for approximately 3-4 months. Once a peptide has been reconstituted with bacteriostatic water, it must be refrigerated to maintain integrity. After reconstitution, peptides typically remain stable for up to 30 days when stored properly.
Lyophilization, also referred to as cryodesiccation, is a specialized dehydration process in which peptides are first frozen and then exposed to a low-pressure environment. This causes the water within the vial to transition directly from a solid to a vapor (sublimation), leaving behind a dry, crystalline white material known as a lyophilized peptide. In this powdered form, peptides may be safely stored at room temperature until they are ready to be reconstituted with bacteriostatic water.
After delivery, peptides should be protected from heat and light. If use is expected within the near future (whether days, weeks, or a few months) refrigerated storage below 4°C (39°F) is generally sufficient. Lyophilized peptides are commonly stable at room temperature for several weeks or longer, making short-term ambient storage acceptable when use is anticipated within that timeframe.
For extended storage, ranging from several months to multiple years, freezing is strongly recommended. Storage at -80°C (-112°F) offers optimal long-term stability and helps preserve peptide structure and quality over time.
For more detailed guidance on peptide handling and storage best practices, please refer to the resource below:
Thymagen is the catalog designation used for the synthetic dipeptide Glu-Trp, represented by the one-letter amino-acid sequence EW. It may also appear in chemical databases under names including Thymogen, glutamyltryptophan, L-alpha-glutamyl-L-tryptophan, and oglufanide.
The compound is supplied as a research material for controlled in-vitro experiments, analytical characterization, comparative peptide studies, assay development, and other qualified laboratory applications. Its availability as a defined two-residue peptide allows researchers to document the test article through established chemical identifiers and lot-specific analytical records.
Descriptions of Thymagen’s research context do not establish safety, efficacy, clinical utility, or suitability for use in humans or animals.
Thymagen (20mg) – Research Specifications:
| Compound | Thymagen |
| Synonyms | Thymogen, glutamyltryptophan, oglufanide |
| Quantity | 20mg per vial |
| Compound Type | Synthetic linear dipeptide |
| Amino-Acid Sequence | Glu-Trp |
| One-Letter Sequence | EW |
| Sequence Length | Two amino-acid residues |
| Molecular Formula | C16H19N3O5 |
| Molecular Weight | 333.34 g/mol |
| CAS Number | 38101-59-6 |
| PubChem CID | 100094 |
| Appearance | Lyophilized peptide powder |
| Purity and Identity | Consult the lot-specific Certificate of Analysis |
| Storage Conditions | Keep sealed and protect from heat, light, and moisture; follow lot-specific documentation |
| Research Classification | For controlled laboratory research only |
| Prohibited Uses | Not for human or animal use, consumption, diagnostic, therapeutic, veterinary, food, cosmetic, or dietary-supplement applications |
Thymagen is a synthetic dipeptide composed of glutamic acid and tryptophan joined by a peptide bond. Its short, chemically defined sequence makes it suitable for controlled analytical work in which researchers evaluate peptide identity, purity, physicochemical behavior, stability, degradation, or molecular interactions under established laboratory conditions.
Thymagen may be evaluated in in-vitro research involving peptide signaling assays and thymus-associated cellular models. These descriptions identify areas of laboratory investigation only. They do not indicate that the material provides a biological benefit or is suitable for clinical, consumer, or veterinary applications.
Experiments involving Thymagen should use validated methods, appropriate controls, documented acceptance criteria, and laboratory procedures suitable for the selected test system.
Important Research Notice: NordSci research materials are supported by lot-specific analytical documentation. Researchers should review the applicable Certificate of Analysis before incorporating a material into an experimental workflow.
THIS PRODUCT IS INTENDED FOR LABORATORY RESEARCH USE ONLY. NOT FOR HUMAN OR ANIMAL CONSUMPTION. NOT INTENDED TO DIAGNOSE, TREAT, CURE, MITIGATE, OR PREVENT ANY DISEASE OR CONDITION.
Qualified laboratories may evaluate Thymagen as a test article in controlled in-vitro assays involving immune-associated signaling markers or molecular interaction pathways. Any observed response must be interpreted within the limits of the specific assay, model, controls, and experimental conditions.
This research context does not establish a therapeutic effect, enhancement of immune function, or suitability for human or veterinary use.
Thymagen may be included in controlled cellular or biochemical models designed to investigate peptide interactions associated with thymus-derived research systems. These experiments may compare measured responses across concentrations, controls, reference standards, or other defined laboratory variables.
Results from an experimental model should not be extrapolated to clinical or consumer outcomes.
Laboratories may use Thymagen in analytical studies examining peptide stability, degradation behavior, cellular assay responses, or sequence-specific molecular interactions. Suitable negative controls, positive controls, replicates, and predefined measurement criteria should be incorporated where appropriate.
The term “cellular maintenance research” describes an experimental category and does not imply that the material maintains, restores, or improves tissue or cellular function.
Thymagen may be evaluated in controlled in-vitro systems that measure predefined markers associated with cellular stress-response pathways. Researchers should document the model, exposure conditions, analytical method, and interpretation limits before drawing conclusions from experimental results.
Research findings involving isolated cells, biochemical systems, or other laboratory models do not establish safety, efficacy, or clinical relevance.
Thymagen (20mg) should be handled only by qualified personnel using appropriate laboratory procedures, personal protective equipment, environmental controls, and material documentation.
Maintain records for the product name, lot number, storage history, preparation date, solvent system, assay conditions, and analytical results. Avoid repeated environmental exposure and unnecessary freeze-thaw cycles when these variables could affect sample integrity.
Protocol Design Considerations: Experimental results may be affected by concentration, solvent compatibility, pH, temperature, incubation period, assay format, sample handling, analytical sensitivity, and control selection. Researchers should validate these variables for the specific laboratory method being used.
No personal-use or veterinary-use instructions are provided or implied.
This information is provided exclusively for qualified laboratory research. The purchaser is responsible for complying with applicable institutional, local, state, and federal requirements governing research materials.
NordSci Peptides makes lot-specific analytical documentation available for Thymagen (20mg). The applicable Certificate of Analysis should be reviewed to confirm the reported identity, purity result, analytical method, lot number, and other documented specifications.
A COA applies only to the identified lot and should not be treated as evidence of clinical safety, therapeutic effectiveness, or suitability for human or animal use.
NordSci Peptides supplies Thymagen (20mg) as a research-grade laboratory material supported by lot-specific documentation. Laboratories evaluating a supplier should review compound identifiers, analytical records, packaging information, storage requirements, batch traceability, and research-use restrictions before purchasing.
IMPORTANT: Thymagen (20mg) is sold exclusively for laboratory research. It is not a drug, food, cosmetic, dietary supplement, or veterinary product. It is not intended for human or animal consumption, diagnostic procedures, or therapeutic applications.
